#TITLE_ALTERNATIVE#
Diabetes Mellitus (DM) is a metabolic disorder characterized by hyperglycemia. WHO has reported <br /> <br /> that diabetes was the cause of 1.6 million death in 2015. Many patients who suffered from diabetes <br /> <br /> used herbs as a complementary or alternative medicine...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/27144 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
id |
id-itb.:27144 |
---|---|
spelling |
id-itb.:271442018-09-28T09:49:13Z#TITLE_ALTERNATIVE# NIM : 10714019, FANNY Indonesia Final Project INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/27144 Diabetes Mellitus (DM) is a metabolic disorder characterized by hyperglycemia. WHO has reported <br /> <br /> that diabetes was the cause of 1.6 million death in 2015. Many patients who suffered from diabetes <br /> <br /> used herbs as a complementary or alternative medicine. Previous studies have shown <br /> <br /> antihyperglycemic activity of mangosteen rind extract (EM) containing α-mangostin (AM). The aim of <br /> <br /> this research was to evaluate the utilization of EM and AM multiple doses and determine possibility <br /> <br /> of pharmacokinetic and pharmacodynamic interaction of single dose metformin (MFN) with either <br /> <br /> pure AM or EM. This research was performed on alloxan-induced diabetic Wistar rats. EM (248 mg/kg <br /> <br /> BW/day) and pure AM (37.2 mg/kg BW/day) were given as multiple doses for 14 days, whereas MFN <br /> <br /> was given as a single dose (100 mg/kg BW/day). The study was performed in 5 groups, which received <br /> <br /> EM, pure AM, combination of EM and MFN, combination of pure AM and MFN, and the fifth group as <br /> <br /> control, respectively. MFN and AM concentrations in plasma were determined using HPLC. Plasma <br /> <br /> glucose levels were measured by GOD-PAP method. Pharmacokinetic parameters of MFN and AM and <br /> <br /> AAC values were calculated. MFN administration did not affect the AM pharmacokinetics of both <br /> <br /> extract and pure form following 14 days administration. EM that was given in 14 days affected the <br /> <br /> distribution and clearance of MFN while the pure AM did not give any effect. The administration of <br /> <br /> 14 days of pure AM had a better blood sugar lowering effect (AAC increased by 104%) than pure AM <br /> <br /> 14 days combined with MFN but differed insignificantly if given in EM form. The administration of AM <br /> <br /> in the pure form (AAC increased by 59%) was better than in the EM form. <br /> text |
institution |
Institut Teknologi Bandung |
building |
Institut Teknologi Bandung Library |
continent |
Asia |
country |
Indonesia Indonesia |
content_provider |
Institut Teknologi Bandung |
collection |
Digital ITB |
language |
Indonesia |
description |
Diabetes Mellitus (DM) is a metabolic disorder characterized by hyperglycemia. WHO has reported <br />
<br />
that diabetes was the cause of 1.6 million death in 2015. Many patients who suffered from diabetes <br />
<br />
used herbs as a complementary or alternative medicine. Previous studies have shown <br />
<br />
antihyperglycemic activity of mangosteen rind extract (EM) containing α-mangostin (AM). The aim of <br />
<br />
this research was to evaluate the utilization of EM and AM multiple doses and determine possibility <br />
<br />
of pharmacokinetic and pharmacodynamic interaction of single dose metformin (MFN) with either <br />
<br />
pure AM or EM. This research was performed on alloxan-induced diabetic Wistar rats. EM (248 mg/kg <br />
<br />
BW/day) and pure AM (37.2 mg/kg BW/day) were given as multiple doses for 14 days, whereas MFN <br />
<br />
was given as a single dose (100 mg/kg BW/day). The study was performed in 5 groups, which received <br />
<br />
EM, pure AM, combination of EM and MFN, combination of pure AM and MFN, and the fifth group as <br />
<br />
control, respectively. MFN and AM concentrations in plasma were determined using HPLC. Plasma <br />
<br />
glucose levels were measured by GOD-PAP method. Pharmacokinetic parameters of MFN and AM and <br />
<br />
AAC values were calculated. MFN administration did not affect the AM pharmacokinetics of both <br />
<br />
extract and pure form following 14 days administration. EM that was given in 14 days affected the <br />
<br />
distribution and clearance of MFN while the pure AM did not give any effect. The administration of <br />
<br />
14 days of pure AM had a better blood sugar lowering effect (AAC increased by 104%) than pure AM <br />
<br />
14 days combined with MFN but differed insignificantly if given in EM form. The administration of AM <br />
<br />
in the pure form (AAC increased by 59%) was better than in the EM form. <br />
|
format |
Final Project |
author |
NIM : 10714019, FANNY |
spellingShingle |
NIM : 10714019, FANNY #TITLE_ALTERNATIVE# |
author_facet |
NIM : 10714019, FANNY |
author_sort |
NIM : 10714019, FANNY |
title |
#TITLE_ALTERNATIVE# |
title_short |
#TITLE_ALTERNATIVE# |
title_full |
#TITLE_ALTERNATIVE# |
title_fullStr |
#TITLE_ALTERNATIVE# |
title_full_unstemmed |
#TITLE_ALTERNATIVE# |
title_sort |
#title_alternative# |
url |
https://digilib.itb.ac.id/gdl/view/27144 |
_version_ |
1822021222312968192 |